Past Event

Tackling antimicrobial resistance (AMR)

Pathological microbes are increasingly resistant to antimicrobial treatments. The resulting health crisis is one of the greatest challenges facing society. At this event, Jim O'Neill will present the Independent Review on Antimicrobial Resistance and a panel will discuss how to tackle drug resistance.

Date: July 14, 2016, 12:30 pm Topic: Innovation & Competition Policy

Summary

See below for video and presentation.

The medical community has identified antimicrobial resistance as a major issue for human beings. In fact, drug resistance poses a threat to our future development and prosperity, as well as to our health. According to recent studies, the number of deaths attributable to AMR in 2050 could equal 10 million. The figure is alarming, making the estimated number of AMR deaths larger than the amount of victims attributable to cancer (8.2 million in 2050).

Because of its relevance, the AMR must also be treated as an economic issue, and the Review on Antimicrobial Resistance commissioned by the UK government in 2014 is playing a key role for this purpose. A ten-point plan has been developed in the Review for tackling AMR, with public awareness being on top of the list, since the problem is ignored in our society. In order to fight the issue, information campaigns should be carried out, as most people appear to have no clue of what antimicrobial resistance is and why it represents a huge threat. A rise in public awareness towards antimicrobial resistance would also bring results, if people proactively react to it. In fact, a way to reduce the impact of the problem is increasing sanitation and hygiene, which could be done by individuals and constitutes the most effective way of facing the issue.

The plan to tackle AMR suggests to stop using antibiotics in agriculture, environment and food processing. To this extent, more transparency from food producers and retailers and in the whole agricultural sector is needed. In general, our society has to increase surveillance on how antibiotics are used in these fields as well as in medicine. The reduction in use and prescriptions of antibiotics would limit the evolution of bacteria. Rapid and efficient diagnostics could also help: sometimes antibiotics are not useful in medical treatments, and the abuse in prescriptions can only worsen the issue. Antibiotics should only be prescribed if a diagnostic technique is used to prove to the necessity of their use. As an alternative, the medical community should boost the role of vaccines, which would partly reduce the use of antibiotics.

On the research side, new drugs should be developed, both to treat patients with pharmaceutical products other than antibiotics and to tackle antimicrobial resistance directly. However, this also requires an increase in investments in research and global innovation funding: funds from a multiplicity of international stakeholders should be allocated and spent on research in a coordinated and strategic way. It is important to emphasize that action to tackle AMR should be conducted on a global basis, and support to achieve international agreements on what has to be done is needed.

Just committing resources, however, does not lead to the solution of the problem itself. Efforts from policy makers can play a central role. The scarce attention of policy makers to date regarding AMR can be attributed to the low level of information and a missing economic quantification of the problem, both of which would increase the awareness of policy-makers towards it. Moreover, the European Commission also needs directives to clarify which roles it could play as a stakeholder and policy-maker and how it can act in order to influence global action.

As a final remark, we should keep in mind that if we are able, as a global society, to build up an effective and sustainable model for funding research, the issue of AMR can be handled and its impact reduced.

Event notes by Domenico Favoino, Research Assistant

VIDEO RECORDING


Event Materials

The Review on Antimicrobial Resistance: global solutions to drug-resistant infections | Presentation by Jim O’Neill

 

Speakers

James Anderson

Head of Corporate Government Affairs, GlaxoSmithKline

Sally Davies

Chief Medical Officer for England

Charles Knirsch

Vice President, Therapeutic Vaccines Program Lead, Vaccine Clinical Research and Development, Pfizer

Jim O‘Neill

Xavier Prats Monné

Director General, European Commission, DG SANTE

Karen E. Wilson

Former Non-resident Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Matilda Sevon

[email protected]

Read about event More on this topic
 

Past Event

Past Event

Evaluating the European Commission’s control of state aid in the banking sector

Evaluating European Commission’s control of state aid to banks in the period 2013-2018.

Speakers: Mihails Kozlovs and Nicolas Véron Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: October 8, 2020
Read about event More on this topic
 

Past Event

Past Event

From playing field to player: Europe’s strategic autonomy as our generation’s goal

At this online event Charles Michel spoke about the importance of Europe's strategic autonomy.

Speakers: Charles Michel and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: September 28, 2020
Read about event
 

Past Event

Past Event

Bruegel Annual Meetings 2020 - Day 3

Third day of Bruegel Annual Meetings.

Topic: Energy & Climate, European Macroeconomics & Governance, Finance & Financial Regulation, Global Economics & Governance, Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: September 3, 2020
Read about event
 

Past Event

Past Event

Bruegel Annual Meetings 2020 - Day 2

Second day of Bruegel Annual Meetings.

Topic: Energy & Climate, European Macroeconomics & Governance, Finance & Financial Regulation, Global Economics & Governance, Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: September 2, 2020
Read about event
 

Past Event

Past Event

Bruegel Annual Meetings 2020 - Day 1

The Annual Meetings are Bruegel's flagship event which gathers high-level speakers to discuss the economic topics that affect Europe and the world.

Topic: Energy & Climate, European Macroeconomics & Governance, Finance & Financial Regulation, Global Economics & Governance, Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: September 1, 2020
Read about event More on this topic
 

Past Event

Past Event

The Euro area after COVID-19 - a conversation with Mario Centeno

At this event we will welcome Mario Centeno to talk about his time as President of the Eurogroup and reflect on the future of the Euro area.

Speakers: Mário Centeno and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: July 1, 2020
Read about event More on this topic
 

Past Event

Past Event

The need for market-based finance after COVID-19

How do COVID-19-caused financial dislocations inform policy responses?

Speakers: Maria Demertzis, Gabriel Makhlouf and Guntram B. Wolff Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 29, 2020
Read about event More on this topic
 

Past Event

Past Event

Redefining Europe's role after the COVID-19 pandemic

Amidst COVID-19: how to keep markets integrated when states play a bigger role in the EU and its neighbourhood?

Speakers: Gabriele Bischoff, John Erik Fossum, Kalypso Nicolaïdis and Guntram B. Wolff Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 25, 2020
Read about event More on this topic
 

Past Event

Past Event

The role of AI in healthcare

How can AI help us fight through a pandemic crisis?

Speakers: Dimitris Bertsimas, Georgios Petropoulos, Effy Vayena and Reinhilde Veugelers Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 23, 2020
Read about event More on this topic
 

Past Event

Past Event

Biological threats and EU preparedness: How can we make the system more resilient?

Can the EU handle biological threats?

Speakers: Maria Demertzis, Magnus Normark, Ilkka Salmi, Jukka Savolainen, Anne Sénéquier and Reinhilde Veugelers Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: June 18, 2020
Read article More on this topic More by this author
 

Opinion

What if the rest of Europe follows Italy's coronavirus fate?

The silence from Brussels could be as damaging as the silence on Italian streets

By: Simone Tagliapietra Topic: Global Economics & Governance Date: March 11, 2020
Read article More by this author
 

Opinion

Europe may be the world’s AI referee, but referees don’t win

The EU needs to invest in homegrown technology.

By: Guntram B. Wolff Topic: European Macroeconomics & Governance, Innovation & Competition Policy Date: February 19, 2020
Load more posts